Domača stranBSX • NYSE
add
Boston Scientific
75,75 $
Pred odprtjem:(1,25 %)−0,95
74,80 $
Konec trgovanja: 27. feb., 08:18:08 GMT -5 · USD · NYSE · Izjava
Prejšnji trg. dan.
73,48 $
Dnevni razpon
73,66 $ - 75,87 $
Letni razpon
72,69 $ - 109,50 $
Tržna kapitalizacija
112,40 mrd. USD
Povprečni obseg
18,56 mio.
Razm. P/E
39,06
Dividendna donosnost
-
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 5,29 mrd. | 15,90 % |
Stroški poslovanja | 2,63 mrd. | 14,59 % |
Čisti dohodek | 672,00 mio. | 18,94 % |
Čista dobičkovnost prihodkov | 12,71 | 2,58 % |
Earnings per share | 0,80 | 14,29 % |
EBITDA | 1,41 mrd. | 23,55 % |
Efektivna davčna stopnja | 4,29 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,96 mrd. | 374,64 % |
Skupna sredstva | 43,67 mrd. | 10,86 % |
Skupne obveznosti | 19,20 mrd. | 10,40 % |
Celoten lastniški kapital | 24,47 mrd. | — |
Shares outstanding | 1,48 mrd. | — |
Razmerje P/B | 4,50 | — |
Donosnost sredstev | 6,03 % | — |
Donosnost kapitala | 7,22 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 672,00 mio. | 18,94 % |
Denar iz dejavnosti | 1,36 mrd. | −6,32 % |
Denar iz naložb | −512,00 mio. | 86,18 % |
Denar iz financiranja | −184,00 mio. | −185,98 % |
Neto sprememba denarnih sredstev | 671,00 mio. | 132,83 % |
Prost denarni tok | 815,38 mio. | 31,78 % |
Vizitka
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator.
Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
Generalni direktor
Datum ustanovitve
29. jun. 1979
Sedež organizacije
Spletno mesto
Zaposleni
59.000
